Literature DB >> 8707342

Antigen presentation in the murine oral epithelium.

K Eriksson1, E Ahlfors, A George-Chandy, D Kaiserlian, C Czerkinsky.   

Abstract

We have previously reported that the buccal mucosa can support delayed type hypersensitivity (DTH) reactions to contact sensitizers. In the present study, we show that cells isolated from the buccal epithelium are able to present soluble exogenous antigens to specific T cells. Single cell suspensions obtained by enzymatic dispersion of buccal epithelial sheets could present the native protein antigen hen-egg lysozyme (HEL) to the I-Ak-restricted CD4+ T-cell hybridoma specific for a.a 46-61 on HEL. T-cell activation resulted in interleukin-2 (IL-2) production which could be inhibited by anti-major histocompatibility complex (MHC) class-II antibodies of pertinent specificity. Immunohistochemical staining of whole buccal epithelial sheets revealed that all MHC II positive cells had a dendritic morphology and expressed ATPase activity, indicating that these cells represent a major antigen-presenting cell (APC) population in this tissue. Furthermore, single cell suspensions isolated from buccal epithelium (BEC) after local in vivo administration of either a native soluble protein, a synthetic dodecapeptide, or a contact sensitizer were able to activate antigen-specific T cells ex vivo. Kinetic analyses indicated that maximal APC activity in the oral epithelium occurred within 1 hr after local antigen administration, and had essentially vanished after 24 hr. Conversely, APC activity was undetectable in draining cervico-mandibular lymph node cell suspensions recovered 1 hr after local antigen injection but became manifest after 3-24 hr. These observations suggest that dendritic cells can acquire antigens in the buccal epithelium and migrate to draining lymph nodes where they present processed antigen to MHC class II-restricted T cells. This APC population may thus be a critical element in the initiation of Th1-driven DTH responses in the oral mucosa.

Entities:  

Mesh:

Year:  1996        PMID: 8707342      PMCID: PMC1456467          DOI: 10.1046/j.1365-2567.1996.d01-647.x

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  21 in total

1.  Cytochemical identification of ATPase-positive langerhans cells in EDTA-separated sheets of mouse epidermis.

Authors:  I C Mackenzie; C A Squier
Journal:  Br J Dermatol       Date:  1975-05       Impact factor: 9.302

2.  Properties of monoclonal antibodies to mouse Ig allotypes, H-2, and Ia antigens.

Authors:  V T Oi; P P Jones; J W Goding; L A Herzenberg; L A Herzenberg
Journal:  Curr Top Microbiol Immunol       Date:  1978       Impact factor: 4.291

3.  Oral lesions of lupus erythematosus patients in relation to other chronic inflammatory oral diseases: an immunologic study.

Authors:  R Sanchez; R Jonsson; E Ahlfors; K Bäckman; C Czerkinsky
Journal:  Scand J Dent Res       Date:  1988-12

4.  Counting and sizing of epidermal cells in normal human skin.

Authors:  P R Bergstresser; R J Pariser; J R Taylor
Journal:  J Invest Dermatol       Date:  1978-05       Impact factor: 8.551

5.  Two types of murine helper T cell clone. II. Delayed-type hypersensitivity is mediated by TH1 clones.

Authors:  D J Cher; T R Mosmann
Journal:  J Immunol       Date:  1987-06-01       Impact factor: 5.422

6.  Granulocyte/macrophage colony-stimulating factor is essential for the viability and function of cultured murine epidermal Langerhans cells.

Authors:  M D Witmer-Pack; W Olivier; J Valinsky; G Schuler; R M Steinman
Journal:  J Exp Med       Date:  1987-11-01       Impact factor: 14.307

7.  Localization of antigen on lymph node dendritic cells after exposure to the contact sensitizer fluorescein isothiocyanate. Functional and morphological studies.

Authors:  S E Macatonia; S C Knight; A J Edwards; S Griffiths; P Fryer
Journal:  J Exp Med       Date:  1987-12-01       Impact factor: 14.307

8.  Direct evidence that a class II molecule and a simple globular protein generate multiple determinants.

Authors:  P M Allen; D J McKean; B N Beck; J Sheffield; L H Glimcher
Journal:  J Exp Med       Date:  1985-10-01       Impact factor: 14.307

9.  Murine epidermal Langerhans cells mature into potent immunostimulatory dendritic cells in vitro.

Authors:  G Schuler; R M Steinman
Journal:  J Exp Med       Date:  1985-03-01       Impact factor: 14.307

10.  Dendritic cell loss from nonlymphoid tissues after systemic administration of lipopolysaccharide, tumor necrosis factor, and interleukin 1.

Authors:  J A Roake; A S Rao; P J Morris; C P Larsen; D F Hankins; J M Austyn
Journal:  J Exp Med       Date:  1995-06-01       Impact factor: 14.307

View more
  10 in total

1.  Dendritic cells and the handling of antigen.

Authors:  F Dieli
Journal:  Clin Exp Immunol       Date:  2003-11       Impact factor: 4.330

Review 2.  Dendritic cells at the oral mucosal interface.

Authors:  C W Cutler; R Jotwani
Journal:  J Dent Res       Date:  2006-08       Impact factor: 6.116

Review 3.  Oral mucosal dendritic cells and periodontitis: many sides of the same coin with new twists.

Authors:  Christopher W Cutler; Yen-Tung A Teng
Journal:  Periodontol 2000       Date:  2007       Impact factor: 7.589

Review 4.  Dendritic cells of the oral mucosa.

Authors:  A-H Hovav
Journal:  Mucosal Immunol       Date:  2013-06-12       Impact factor: 7.313

5.  Electroporation mediated DNA vaccination directly to a mucosal surface results in improved immune responses.

Authors:  Gleb Kichaev; Janess M Mendoza; Dinah Amante; Trevor R F Smith; Jay R McCoy; Niranjan Y Sardesai; Kate E Broderick
Journal:  Hum Vaccin Immunother       Date:  2013-06-11       Impact factor: 3.452

6.  The murine buccal mucosa is an inductive site for priming class I-restricted CD8+ effector T cells in vivo.

Authors:  C Desvignes; F Estèves; N Etchart; C Bella; C Czerkinsky; D Kaiserlian
Journal:  Clin Exp Immunol       Date:  1998-09       Impact factor: 4.330

7.  Identification of three distinct subsets of migrating dendritic cells from oral mucosa within the regional lymph nodes.

Authors:  Narumon Chalermsarp; Miyuki Azuma
Journal:  Immunology       Date:  2009-08       Impact factor: 7.397

8.  Langerhans' cells in the murine oral mucosa in the inductive phase of delayed type hypersensitivity with 1-chloro-2, 4-dinitrobenzene.

Authors:  T Okamura; M Morimoto; G Yamane; S Takahashi
Journal:  Clin Exp Immunol       Date:  2003-11       Impact factor: 4.330

9.  Enhanced efficacy of sublingual immunotherapy by liposome-mediated delivery of allergen.

Authors:  Have Aliu; Carola Rask; Jens Brimnes; Thomas Lars Andresen
Journal:  Int J Nanomedicine       Date:  2017-11-22

Review 10.  Buccal and sublingual vaccine delivery.

Authors:  Heleen Kraan; Hilde Vrieling; Cecil Czerkinsky; Wim Jiskoot; Gideon Kersten; Jean-Pierre Amorij
Journal:  J Control Release       Date:  2014-06-06       Impact factor: 9.776

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.